{
  "id": 10540881,
  "title": "Insurance Formularies Holding Up Lower-Emission Asthma, COPD Inhalers",
  "url": "https://urgent.news/2026/09/28/insurance-formularies-holding-up-lower-emission-asthma-copd-inhalers",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-28T20:39:41.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/pulmonology/asthma/123176"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Commercial insurance formularies have posed a barrier to cutting greenhouse gas emissions from metered-dose inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD), a study showed. Lower-emission versions...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}